LAS VEGAS--(BUSINESS WIRE)--Nutri Pharmaceuticals Research Inc. (Pink Sheets: NRPR - News), a leading developer and marketer of powdered nutritional ingredients, announces that it is relocating its executive offices and operations facility to the Hughes Airport Center near the McCarran International Airport. The Company has outgrown its current 10,000 SF facility and needs additional space to meet the growth in demand of its products and for upgrades to its manufacturing operations. The new company address is 6780 Caballo St, Las Vegas, NV 89119. This new facility is approximately 31,000 SF. The Company will use 5,000 SF as offices. The balance will be used for a new state-of-the-art laboratory, production lines and warehouse space.
We will be adding an additional production line to the new facility, which will enable the Company to double its production output.
Godfrey Yew, the Company's President stated, "We strongly believed that this new facility will enable the Company to achieve three significant goals, (1) increase our production and warehouse space, (2) meet the facility requirements for a CGMP (Current Good Manufacturing Practice) certification, and (3) meet the facility requirements for a USDA facility certification. We believe these certifications are essential to grow our business because an increasing number of potential customers require these certifications."
The Company has experienced significant sales growth during 2006 and believes that this trend will continue. The new facility should enable the Company to elevate its manufacturing practices to a higher standard, which should permit us to sell our products to a broader base of customers.
Nutri Pharmaceuticals Research Inc. (www.o2pus.com) provides a wide range of powdered oils for functional food; food supplement; pharmaceutical; cosmetic; pet food and animal feed applications. The company is one of a select few to be awarded the prestigious Nutrition Business Journal "Product Merit Award" for its patent-pending O2P(TM) Powderization process. At the heart of its oil powders is the O2P(TM) Oil-to-Powder technology. This patent-pending process converts most edible oils, gels or pastes into a free-flowing powder without affecting the isomeric structure, fatty acid profile, color, taste or aroma of the base oil. O2P(TM) does not rely on traditional techniques that utilize extremes in heat or cold, or micro-encapsulation technology. This facilitates food marketing and supplement producers' ability to create functional foods and nutraceuticals by adding anti-oxidants, specific EFAs, or other fatty acids such as EPA, GLA, DHA, and CLA to assist in maintaining specific health issues. The company currently offers more than 50 shelf-stable powders. The company can also apply O2P(TM) technology to a third-party's oil, paste or gel through an arrangement called tolling. Based in Las Vegas, the company has representative sales offices near Chicago, Amsterdam, Guatemala City and Bangkok. Nutri Pharmaceuticals Research Inc. shares are currently traded in the United States on the "Pink Sheets" under the symbol NRPR.PK.